Table 2.
Serum levels of LEAP2, ghrelin, ghrelin/LEAP2 ratio in healthy adults and T2D subjects, and in male and female groups (normal n = 27: 19M+8F; T2DM n = 29: 21M+8F). Data are presented as median (IQR) for LEAP2. Ghrelin and ghrelin/LEAP2 are presented as mean (95% CI).
| Normal | T2D | P value | |||||
|---|---|---|---|---|---|---|---|
| All | Male | Female | All | Male | Female | ||
| LEAP2 (ng/mL) | 1.61 (1.35; 2.23) | 1.59 (1.32; 2.13) | 1.83 (1.43; 2.58) | 3.55 (1.64; 5.90) | 3.37 (1.64; 5.90) | 3.40 (1.28; 6.08) | 0.0080 |
| Ghrelin (ng/mL) | 50.88 (41.57; 60.20) | 47.54 (37.02; 58.05) | 58.83 (36.17; 81.49) | 37.46 (31.74; 43.17) | 34.68 (29.57; 39.79) | 44.75 (26.85; 62.65) | 0.0296 |
| Ghrelin/LEAP2 | 30.22 (23.14; 37.31) | 29.96 (21.68; 38.24) | 30.85 (13.47; 48.23) | 14.60 (10.63; 18.57) | 18.41 (12.54; 24.28) | 17.05 (6.79; 27.30) | 0.0005 |
Bold values are statistically significant (P < 0.05).
LEAP2, liver-expressed antimicrobial peptide 2; T2D, type 2 diabetes.
This work is licensed under a